Holen Sie sich die Stockscreener-App
375.93
2.03%
-7.79
Handel nachbörslich:
375.01
-0.92
-0.24%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SYK?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$383.72
Offen:
$382.4
24-Stunden-Volumen:
1.31M
Relative Volume:
1.00
Marktkapitalisierung:
$143.72B
Einnahmen:
$23.82B
Nettoeinkommen (Verlust:
$2.92B
KGV:
49.74
EPS:
7.5574
Netto-Cashflow:
$4.02B
1W Leistung:
-1.01%
1M Leistung:
+1.87%
6M Leistung:
+2.58%
1J Leistung:
+5.60%
1-Tages-Spanne:
$375.70
$383.06
1-Wochen-Bereich:
$375.70
$392.55
52-Wochen-Spanne:
$329.16
$406.19
Stryker Corp Stock (SYK) Company Profile
Firmenname
Stryker Corp
Sektor
Branche
Telefon
(269) 385-2600
Adresse
1941 STRYKER WAY, PORTAGE, MI
Vergleichen Sie SYK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
375.93 | 146.70B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
ABT
Abbott Laboratories
|
126.61 | 221.35B | 43.84B | 13.94B | 6.78B | 7.9979 |
|
BSX
Boston Scientific Corp
|
100.97 | 151.78B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
MDT
Medtronic Plc
|
93.23 | 120.73B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.19 | 47.45B | 5.69B | 1.41B | 577.90M | 6.9828 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-18 | Eingeleitet | Rothschild & Co Redburn | Neutral |
| 2025-02-26 | Fortgesetzt | Citigroup | Buy |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-10 | Eingeleitet | Wolfe Research | Outperform |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-22 | Hochstufung | Needham | Hold → Buy |
| 2024-01-31 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-09-05 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-01-25 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2023-01-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-11-01 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-28 | Hochstufung | Edward Jones | Hold → Buy |
| 2022-07-21 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-07-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-13 | Eingeleitet | Truist | Hold |
| 2022-03-16 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-03-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-12-07 | Eingeleitet | Loop Capital | Buy |
| 2021-09-14 | Fortgesetzt | Raymond James | Mkt Perform |
| 2021-07-28 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2021-06-01 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Underweight |
| 2020-10-06 | Eingeleitet | Northland Capital | Market Perform |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-04-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-04-01 | Herabstufung | Goldman | Buy → Sell |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Hold |
| 2020-01-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-12-30 | Bestätigt | BTIG Research | Buy |
| 2019-11-05 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-10-30 | Bestätigt | BofA/Merrill | Buy |
| 2019-07-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-01-30 | Bestätigt | Canaccord Genuity | Buy |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2019-01-02 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-08-16 | Eingeleitet | BTIG Research | Buy |
| 2018-06-27 | Eingeleitet | Bernstein | Mkt Perform |
| 2018-04-27 | Bestätigt | Stifel | Buy |
Alle ansehen
Stryker Corp Aktie (SYK) Neueste Nachrichten
How Stryker Corporation stock performs in easing cyclesTrade Volume Summary & Advanced Technical Analysis Signals - newser.com
Can Stryker Corporation (SYK) stock hold up in economic slowdownTrade Exit Summary & Long Hold Capital Preservation Tips - newser.com
How Stryker Corporation stock reacts to weak economyJuly 2025 Recap & Growth Focused Stock Reports - newser.com
Is Stryker Corporation (SYK) stock cheap vs fundamentalsWeekly Risk Report & AI Based Buy and Sell Signals - newser.com
Is Stryker Corporation stock ready for breakoutJuly 2025 Pullbacks & Free Safe Capital Growth Stock Tips - newser.com
Can machine learning forecast Stryker Corporation recoveryTrade Volume Summary & Entry Point Strategy Guides - newser.com
Stryker Corp. Experiences Valuation Adjustment Amid Competitive Market Landscape - Markets Mojo
Stryker Corp. Experiences Valuation Adjustment Amidst Competitive Market Landscape - Markets Mojo
What Analyst Projections for Key Metrics Reveal About Stryker (SYK) Q3 Earnings - Yahoo Finance
Joint Reconstruction Devices Market 2025-2032: New Technologies are Transforming the Landscape, Reaching $149 Billion by 2032 - GlobeNewswire Inc.
Is Stryker Corporation stock expanding market penetration2025 Retail Activity & Stepwise Trade Signal Implementation - newser.com
Can Stryker Corporation rally from current levelsJuly 2025 Reactions & Safe Capital Preservation Plans - newser.com
Why Stryker Corporation stock remains top rated2025 Institutional Moves & Fast Exit Strategy with Risk Control - newser.com
Key metrics from Stryker Corporation’s quarterly dataShare Buyback & Real-Time Buy Signal Notifications - newser.com
Why Stryker Corporation (SYK) stock could outperform next year - newser.com
Will Stryker Corporation stock gain from strong economyJuly 2025 Intraday Action & Daily Stock Trend Reports - newser.com
Is Stryker Corporation (SYK) stock supported by strong fundamentalsEarnings Miss & Long-Term Growth Plans - newser.com
GCC $1.25+ Bn Catheter Market Growth Trends and Forecast to 2033 Featuring Abbott, Edwards Lifesciences, BD and Co, Boston Scientific, Medtronic, Johnson & Johnson, Stryker, Teleflex - Yahoo Finance
United States Breast Reconstruction Market Growth Trends and Forecast Report 2025-2033, Profiles of Mentor Worldwide, AbbVie, Integra, Sientra, Stryker, Establishment Labs, RTI Surgical, TELA Bio - Yahoo Finance
Stryker Corporation's (NYSE:SYK) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - 富途牛牛
Stryker (SYK) Receives Overweight Rating and Raised Price Target from Barclays | SYK Stock News - GuruFocus
The Zacks Analyst Blog Highlights Moodys, Stryker and CBRE - The Globe and Mail
Tumor Ablation Market Poised for Robust Growth by 2032, Driven by Technological Advancements and Rising Surgical Volumes, DelveInsight | Medtronic PLC, Stryker, Baird Medical Devices Inc., Siemens Hea - Barchart.com
Stryker Corp. Forms Death Cross, Signaling Potential Bearish Trend Ahead - Markets Mojo
Buy 3 Wide Moat Stocks to Enhance Your Portfolio Returns in Q4 - The Globe and Mail
How Stryker Corporation stock reacts to monetary easing2025 Historical Comparison & Risk Controlled Stock Pick Alerts - newser.com
Stryker Corp. stock outperforms competitors on strong trading day - MarketWatch
Stryker Breaks Above 200-Day Moving AverageBullish for SYK - Nasdaq
Zacks.com featured highlights include Stryker, NVIDIA, ResMed and Ralph Lauren - The Globe and Mail
Retail Trends: Is Stryker Corporation (SYK) stock cheap vs fundamentalsMarket Activity Report & Verified Entry Point Detection - Trung tâm Dự báo KTTV quốc gia
Stryker Is Maintained at Hold by Truist Securities - 富途牛牛
What Does Stryker’s Latest Earnings Growth Mean for Its 2025 Valuation? - Yahoo Finance
Finanzdaten der Stryker Corp-Aktie (SYK)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.43%
1.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):